Midwest Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Midwest Wealth Management's BMY Position: Q1 2022 in Review
Midwest Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2022, buying an estimated $151K and bringing the position to 21,450 shares worth $1.57M. The position accounts for 0.95% of the portfolio, ranked #59.
Midwest Wealth Management first reported a position in BMY in Q4 2020 and has held it in 6 quarters since. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- Midwest Wealth Management held 21,450 shares of Bristol-Myers Squibb worth $1.57M as of Q1 2022.
- Midwest Wealth Management bought 2,247 Bristol-Myers Squibb shares in Q1 2022, an estimated $151K.
- Bristol-Myers Squibb made up 0.95% of Midwest Wealth Management's portfolio in Q1 2022, its #59 holding.
- Midwest Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 6 quarters since.
- 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on Midwest Wealth Management's 13F filing for Q1 2022, filed 25 May 2022.